≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Optic neuritis

DOID EFO Endpoint Browser PheWeb

H7_OPTNEURITIS

optic neuritis: Optic neuritis is inflammation of the optic nerve, the nerve that carries the visual signal from the eye to the brain.The conditionmay cause sudden, reduced vision in the affected eye(s). While the cause of optic neuritis is unknown, it has been associated with autoimmune diseases, infections, multiple sclerosis , drug toxicity and deficiency of vitamin B-12. Vision often returns to normal within 2-3 weeks without treatment. In some cases, corticosteroids are given to speed recovery. If known, the underlying cause should be treated.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — H46
  • Hospital discharge: ICD-9 — 3773
  • Hospital discharge: ICD-8 — 3670[2-9]
  • Cause of death: ICD-10 — H46
  • Cause of death: ICD-9 — 3773
  • Cause of death: ICD-8 — 3670[2-9]

2 out of 7 registries used, show all original rules.

1675

4. Check minimum number of events

None

1675

5. Include endpoints

None

1675

6. Filter based on genotype QC (FinnGen only)

1675

Control definitions (FinnGen only)

Control exclude
H7_OPTNERVE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
H46-H48
Name in latin
Neuritis optica

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 10403 6920 3413
Only index persons 9515 6484 3031
Unadjusted period prevalence (%)
Whole population 0.16 0.20 0.10
Only index persons 0.20 0.24 0.12
Median age at first event (years)
Whole population 36.47 35.70 38.00
Only index persons 35.76 35.17 37.00

-FinnGen-

Key figures

All Female Male
Number of individuals 1675 1255 420
Unadjusted period prevalence (%) 0.37 0.43 0.19
Median age at first event (years) 36.20 35.29 38.91

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1513
Matched controls
15131
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H46
ICD-10 Finland
Optic neuritis
4503599627370496.0
323.0
1304
*
109
Kela drug reimbursment
Multiple sclerosis
178.0
323.0
634
61
303
Kela drug reimbursment
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
182.7
323.0
564
49
G35
ICD-10 Finland
Multiple sclerosis
180.5
323.0
773
87
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
181.1
323.0
531
45
L03AB07
ATC
interferon beta-1a; parenteral
167.1
323.0
338
26
XCK00
NOMESCO Finland
Perimetry
19.3
291.3
468
343
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
14.1
282.5
526
550
L03AX13
ATC
glatiramer acetate; parenteral
187.7
245.4
251
16
TAB00
NOMESCO Finland
Lumbar puncture
16.7
228.9
386
304
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
77.7
205.3
231
35
N86
ICPC
Multiple sclerosis
83.6
199.3
222
31
164
Kela drug reimbursment
Fingolimod
117.0
172.6
185
18
L04AX07
ATC
dimethyl fumarate; oral
135.7
159.9
169
14
Z01.0
ICD-10 Finland
Examination of eyes and vision
5.7
150.9
516
1256
353
Kela drug reimbursment
Cladribine and fingolimod
100.7
148.5
162
18
L04AA31
ATC
teriflunomide; oral
121.3
133.6
143
13
L04AA27
ATC
fingolimod; oral
119.5
131.6
141
13
N04BB01
ATC
amantadine; oral
33.5
131.0
173
58
L03AB08
ATC
interferon beta-1b; parenteral
176.1
124.5
129
8
N07XX09
ATC
[U] dimethyl fumarate; oral
139.4
109.7
116
9
36703
ICD-8 Finland
Inflammation of optic nerve and retina, Neuritis optica, retrobulbaris
+∞
109.7
104
*
XCD10
NOMESCO Finland
Electrophysiological examination of eye
17.4
101.5
164
105
H47.0
ICD-10 Finland
Disorders of optic nerve, not elsewhere classified
+∞
99.1
94
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
11.3
95.9
188
187
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
13.7
93.0
166
135
XCW99
NOMESCO Finland
Other investigative procedure of eye
5.4
90.7
302
665
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
12.9
87.0
159
136
H53.1
ICD-10 Finland
Subjective visual disturbances
6.5
85.4
240
426
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
6.0
81.3
244
470
XA800
NOMESCO Finland
Neuropsychological investigation
8.7
79.7
181
233
2AB04
NOMESCO Finland
NA
144.4
77.8
82
6
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
42.9
71.6
89
22
H47.2
ICD-10 Finland
Optic atrophy
+∞
71.4
68
*
F02.89*G35
ICD-10 Finland
Dementia in multiple sclerosis
720.7
70.7
69
*
M03BX01
ATC
baclofen; systemic
13.1
69.8
126
104
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
21.1
67.5
101
51
XKD06
NOMESCO Finland
Physiologic investigation of micturition
10.9
65.3
129
128
3773B
ICD-9 Finland
Disorders of optic nerve and visual pathways, Optic neuritis[NEURITIS RETROBULBARIS]
+∞
65.1
62
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
4.6
64.8
245
604
H47.1
ICD-10 Finland
Papilloedema, unspecified
655.0
64.4
63
*
H48.1*G35
ICD-10 Finland
Retrobulbar neuritis in multiple sclerosis
+∞
64.0
61
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
4.3
61.5
252
671
H53.4
ICD-10 Finland
Visual field defects
15.0
59.0
100
71
ZX120
NOMESCO Finland
Intravenous
4.1
55.6
241
672
G36.0
ICD-10 Finland
Neuromyelitis optica [Devic]
286.3
54.5
55
*
XKD00
NOMESCO Finland
Uroflowmetry
4.0
52.5
233
662
3400A
ICD-9 Finland
Multiple sclerosis[SCLEROSIS MULTIPLEX (DISSEMINATA)]
134.5
49.1
52
*
N06BA07
ATC
modafinil; oral
41.6
48.2
60
15
G36.9
ICD-10 Finland
Acute disseminated demyelination, unspecified
46.3
47.6
58
13
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
10.1
47.6
97
102
Z3231
NOMESCO Finland
Registered nurse
2.4
45.3
481
2436
L03AB13
ATC
peginterferon beta-1a; parenteral
84.4
44.1
49
6
36702
ICD-8 Finland
Inflammation of optic nerve and retina, Neuritis optica. Papillitis
+∞
44.0
42
*
G04BD09
ATC
trospium; oral
9.2
42.9
92
106
XCK10
NOMESCO Finland
Photography of fundus of eye
3.7
42.4
203
610
N03AX12
ATC
gabapentin; oral
2.8
41.3
305
1249
H53.9
ICD-10 Finland
Visual disturbance, unspecified
7.4
41.1
101
145
4AA23
NOMESCO Finland
NA
143.9
39.9
42
*
G04BD12
ATC
mirabegron; oral
3.8
39.8
181
519
R20.2
ICD-10 Finland
Paraesthesia of skin
3.7
38.9
182
535
H57.1
ICD-10 Finland
Ocular pain
5.7
38.1
115
217
R1250
NOMESCO Finland
Evaluation of functional capability
8.6
36.0
80
98
CS494
NOMESCO Finland
Other visual field testing
8.9
35.1
76
89
XKC03
NOMESCO Finland
Water cystometry
6.3
34.8
95
158
UKC02
NOMESCO Finland
Cystoscopy
2.9
34.5
238
925
3773A
ICD-9 Finland
Disorders of optic nerve and visual pathways, Optic neuritis[PAPILLITIS OPTICA]
+∞
34.5
33
*
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
7.8
33.6
79
106
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
4.1
31.9
131
342
H02AB04
ATC
methylprednisolone; systemic
2.6
31.6
269
1179
H53.2
ICD-10 Finland
Diplopia
5.9
29.0
83
147
A02BC02
ATC
pantoprazole; systemic
1.9
28.7
943
7137
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
7.6
28.6
68
93
TKC22
NOMESCO Finland
Catheterisation instruction
9.5
28.6
59
64
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
65.3
28.0
32
5
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
18.4
28.0
43
24
G04BD07
ATC
tolterodine; oral
4.8
27.8
95
207
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
3.8
27.7
125
354
G04BD04
ATC
oxybutynin; oral, transdermal
4.1
27.5
111
285
H02AB06
ATC
prednisolone; systemic
1.8
27.4
695
4791
Z3229
NOMESCO Finland
Other healthcare associate professional
3.1
27.2
156
533
N03AX16
ATC
pregabalin; oral
2.1
27.0
368
2009
N03AE01
ATC
clonazepam; systemic
3.5
26.9
132
401
L04AA40
ATC
cladribine; oral
76.6
26.8
30
*
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
3.1
26.7
161
567
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
14.5
26.7
45
32
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
16.6
26.3
42
26
G04BD08
ATC
solifenacin; oral
3.8
25.9
115
321
34099
ICD-8 Finland
Multiple sclerosis
95.1
25.7
28
*
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
9.1
25.6
54
61
Z3226
NOMESCO Finland
Physiotherapist
2.2
25.1
301
1550
H04.10
ICD-10 Finland
Dry eye syndrome
2.7
25.1
191
781
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
14.4
24.9
42
30
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
4.0
24.1
101
269
G95.8
ICD-10 Finland
Other specified diseases of spinal cord
27.2
23.6
32
12
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.3
23.3
124
400
Z2445
NOMESCO Finland
Psychologist
3.6
22.8
106
308
R33
ICD-10 Finland
Retention of urine
3.7
22.6
103
295
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
11.4
22.0
41
37
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
9.4
21.9
45
49
R35
ICD-10 Finland
Polyuria
3.6
21.6
102
300
R4150
NOMESCO Finland
Neuropsychological rehabilitation
12.1
21.1
38
32
N31.8
ICD-10 Finland
Other neuromuscular dysfunction of bladder
28.5
21.0
28
10
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
20.8
539
3644
TKC20
NOMESCO Finland
Catheterisation of bladder
3.1
19.0
108
366
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
5.0
18.6
60
124
H53.8
ICD-10 Finland
Other visual disturbances
11.2
18.2
34
31
SPAT1229
SPAT
Assessment of need for aid
3.0
18.1
109
383
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
7.2
17.9
43
61
J01EA01
ATC
trimethoprim; systemic
1.8
17.8
392
2498
H48.1
ICD-10 Finland
Retrobulbar neuritis in diseases classified elsewhere
+∞
17.7
17
*
H02AB07
ATC
prednisone; oral
2.1
17.5
213
1089
R51.80
ICD-10 Finland
Headache
1.9
17.4
268
1508
H57.9
ICD-10 Finland
Disorder of eye and adnexa, unspecified
8.4
17.0
37
45
N03AF01
ATC
carbamazepine; oral, rectal
3.3
16.7
87
277
H47.3
ICD-10 Finland
Other disorders of optic disc
+∞
16.7
16
*
R4110
NOMESCO Finland
Physiotherapy
1.8
16.3
357
2262
N32.82
ICD-10 Finland
Instability of the detrusor vesicae muscle
7.1
16.2
39
56
N32.83
ICD-10 Finland
Nozzle synergy in the bladder neck
16.9
16.1
25
15
L28
ICPC
Limited function/disability (L)
2.2
16.1
181
896
C10AC01
ATC
colestyramine; oral
4.3
15.9
59
141
N05CF01
ATC
zopiclone; oral
1.7
15.9
428
2876
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
15.8
388
2539
N28
ICPC
Limited function/disability (N)
7.4
15.8
37
51
H30.2
ICD-10 Finland
Posterior cyclitis
22.3
15.5
22
10
L04AX01
ATC
azathioprine; systemic
3.0
15.3
90
313
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
3.7
15.1
67
189
AA1AD
NOMESCO Finland
CT of head and brain
1.8
15.1
278
1657
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
5.4
14.3
42
79
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.0
14.2
199
1073
XKD03
NOMESCO Finland
Urethral pressure profilometry
4.5
14.1
50
115
G04BD11
ATC
fesoterodine; oral
4.4
13.9
50
117
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
8.7
13.8
29
34
XF400
NOMESCO Finland
ECG with 12 standard connections
2.0
13.7
194
1051
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
9.8
13.7
27
28
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.9
13.7
210
1172
36709
ICD-8 Finland
Inflammation of optic nerve and retina, Unspecified
+∞
13.6
13
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.6
13.3
521
3823
CA1BG
NOMESCO Finland
Eye and orbita MRI examination with high intensity magnet
11.6
13.3
24
21
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
9.8
13.2
26
27
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.4
13.2
115
502
Z2446
NOMESCO Finland
Social worker
2.4
13.2
113
492
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
3.0
13.2
77
268
N31.1
ICD-10 Finland
Reflex neuropathic bladder, not elsewhere classified
13.1
12.9
22
17
CA1DG
NOMESCO Finland
Eye and orbita very extensive MRI examination with high intensity magnet
50.4
12.9
15
*
XCH00
NOMESCO Finland
Eye pressure measurement
3.6
12.8
58
167
R42
ICD-10 Finland
Dizziness and giddiness
1.7
12.6
263
1628
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.4
12.5
106
459
M03BX02
ATC
tizanidine; oral
1.5
12.5
926
7782
G50.0
ICD-10 Finland
Trigeminal neuralgia
5.0
12.4
39
80
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.3
12.3
117
533
N06AX16
ATC
venlafaxine; oral
1.8
12.1
241
1467
H54.4
ICD-10 Finland
Blindness, monocular
26.9
12.1
16
6
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
11.5
264
1678
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
7.9
11.4
25
32
N06AA09
ATC
amitriptyline; systemic
2.1
11.3
138
703
N03AF02
ATC
oxcarbazepine; oral
3.3
11.3
56
174
RF120
NOMESCO Finland
NA
5.7
11.2
31
55
F05
ICPC
Visual disturbance other
3.6
11.0
49
140
R4120
NOMESCO Finland
Occupational therapy
2.4
11.0
93
401
G04CA02
ATC
tamsulosin; oral
1.9
11.0
161
882
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
10.9
530
4037
R50.9
ICD-10 Finland
Fever, unspecified
1.8
10.9
196
1154
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.6
10.7
365
2564
A28
ICPC
Limited function/disability NOS
2.0
10.7
136
707
J01CA08
ATC
pivmecillinam; oral
1.5
10.6
629
4978
Z96.1
ICD-10 Finland
Presence of intraocular lens
2.2
10.6
106
496
Z2221
NOMESCO Finland
Medical doctor
1.5
10.5
406
2938
ZXA10
NOMESCO Finland
Bilateral
1.7
10.5
232
1456
N30.0
ICD-10 Finland
Acute cystitis
1.8
10.4
202
1216
N02BE01
ATC
paracetamol; systemic, rectal
1.5
10.4
1213
10965
H20.1
ICD-10 Finland
Chronic iridocyclitis
5.2
10.3
31
61
S06.0
ICD-10 Finland
Concussion
1.9
10.2
144
778
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
3.6
10.1
44
124
G51.0
ICD-10 Finland
Bell palsy
3.6
10.1
44
125
N99
ICPC
Neurological disease other
5.6
10.0
28
51
SPAT1216
SPAT
Assessment of functional ability
1.8
9.8
163
933
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.5
9.6
346
2455
N29
ICPC
Neurological sympt/complt other
4.1
9.6
36
90
N06AB04
ATC
citalopram; systemic
1.6
9.5
302
2079
G04BD01
ATC
emepronium; systemic
9.1
9.5
19
21
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.5
9.4
72
297
G40.9
ICD-10 Finland
Epilepsy, unspecified
3.0
9.3
51
172
SPAT1231
SPAT
Assessment of adjustments needed in living environment
5.5
9.2
26
48
N05BA01
ATC
diazepam; systemic, rectal
1.8
9.2
171
1017
J01MA02
ATC
ciprofloxacin; systemic
1.4
9.1
470
3594
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.8
9.1
172
1030
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.4
9.0
77
334
L01BB04
ATC
cladribine; systemic
36.9
9.0
11
*
H51.2
ICD-10 Finland
Internuclear ophthalmoplegia
36.9
9.0
11
*
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.8
8.9
143
810
A02BA02
ATC
ranitidine; systemic
1.6
8.9
222
1439
H34.2
ICD-10 Finland
Other retinal artery occlusions
16.4
8.6
13
8
U13
ICPC
Bladder symptom/complaint other
3.0
8.5
47
160
G04CA01
ATC
alfuzosin; oral
2.2
8.5
89
425
ZXE10
NOMESCO Finland
More than one and less than three hours
1.4
8.5
458
3523
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.9
8.5
130
725
N02AX02
ATC
tramadol; systemic, rectal
1.4
8.5
506
3966
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.5
8.4
384
2857
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
6.7
8.4
20
30
R06.0
ICD-10 Finland
Dyspnoea
1.5
8.4
277
1924
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
3.8
8.4
34
92
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.6
8.2
57
223
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
4.7
8.1
26
56
G81.9
ICD-10 Finland
Hemiplegia, unspecified
4.9
8.1
25
52
RF420
NOMESCO Finland
NA
4.1
8.1
30
75
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.8
7.9
136
789
A02BC03
ATC
lansoprazole; oral
1.5
7.8
345
2545
H52.1
ICD-10 Finland
Myopia
2.5
7.8
61
255
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
7.7
286
2032
H43.8
ICD-10 Finland
Other disorders of vitreous body
2.1
7.7
90
452
H54.0
ICD-10 Finland
Blindness, binocular
45.2
7.7
9
*
NA1CM
NOMESCO Finland
Cervical spine extensive MRI examination with 3 Tesla magnet
15.1
7.7
12
8
RF410
NOMESCO Finland
NA
4.6
7.7
25
55
ZXY02
NOMESCO Finland
Neuropsychologist
7.5
7.7
17
23
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.6
7.6
221
1483
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.5
7.6
342
2532
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.7
7.6
157
963
NA1BM
NOMESCO Finland
Cervical spine MRI examination with 3 Tesla magnet
11.9
7.6
13
11
R39.1
ICD-10 Finland
Other difficulties with micturition
3.2
7.5
37
117
A02BC01
ATC
omeprazole; systemic
1.5
7.5
336
2485
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
3.9
7.5
29
76
XA412
NOMESCO Finland
VEP
80.5
7.4
8
*
RS221
NOMESCO Finland
NA
3.8
7.4
29
77
H55
ICD-10 Finland
Nystagmus and other irregular eye movements
8.4
7.3
15
18
G97.1
ICD-10 Finland
Other reaction to spinal and lumbar puncture
10.9
7.3
13
12
3773X
ICD-9 Finland
Disorders of optic nerve and visual pathways, Optic neuritis[NEURITIS OPTICA ALIA SEU NUD]
+∞
7.3
7
*
34109
ICD-8 Finland
Other demyelinating diseases of central nervous system, Unspecified
+∞
7.3
7
*
ZXE21
NOMESCO Finland
Procedure duration at least 3 but less than 4 hours
6.9
7.3
17
25
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.8
7.3
131
773
J01AA02
ATC
doxycycline; systemic
1.4
7.3
1068
9627
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.8
7.3
127
742
N06AX21
ATC
duloxetine; oral
1.7
7.1
157
982
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
6.1
7.1
18
30
A04
ICPC
Weakness/tiredness general
1.6
7.1
166
1057
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.8
7.0
109
612
U07
ICPC
Urine symptom/complaint other
2.1
6.9
71
340
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.3
6.9
779
6709
CS3P4
NOMESCO Finland
Optic nerve head stereophotography
4.6
6.9
22
48
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
6.9
272
1957
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
6.9
492
3950
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
4.5
6.8
22
49
H54.7
ICD-10 Finland
Unspecified visual loss
6.1
6.8
17
28
M31.5
ICD-10 Finland
Giant cell arteritis with polymyalgia rheumatica
6.1
6.8
17
28
4AA36
NOMESCO Finland
NA
40.2
6.8
8
*
S01EC01
ATC
acetazolamide; systemic
3.4
6.7
30
89
N03AX09
ATC
lamotrigine; oral
1.9
6.7
87
459
Z43.5
ICD-10 Finland
Attention to cystostomy
22.6
6.7
9
*
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.7
6.6
141
878
N31.0
ICD-10 Finland
Uninhibited neuropathic bladder, not elsewhere classified
8.7
6.6
13
15
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
10.1
6.5
12
12
J01XE01
ATC
nitrofurantoin; oral
3.2
6.5
31
97
F01
ICPC
Eye pain
2.6
6.5
44
173
H52.5
ICD-10 Finland
Disorders of accommodation
14.4
6.4
10
7
L89
ICD-10 Finland
Decubitus ulcer and pressure area
4.4
6.4
21
48
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.3
6.3
684
5827
H53
ICD-10 Finland
Visual disturbances
5.5
6.3
17
31
R03CA02
ATC
ephedrine; oral
18.1
6.3
9
5
SPAT1325
SPAT
Vaccination
1.4
6.2
372
2889
S30.0
ICD-10 Finland
Contusion of lower back and pelvis
2.4
6.2
51
221
NA7CM
NOMESCO Finland
Spine and spinal cord extensive MRI examination with 3 Tesla magnet
26.8
6.2
8
*
R51.81
ICD-10 Finland
Facial pain NOS
2.8
6.2
37
135
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.6
6.2
148
948
TCW99
NOMESCO Finland
Other minor procedure in eye surgery
4.5
6.2
20
45
Z50.1
ICD-10 Finland
Other physical therapy
2.1
6.2
66
324
A06AD11
ATC
lactulose; oral
1.7
6.1
132
821
CJB10
NOMESCO Finland
Laser discission of secondary cataract
2.1
6.1
61
290
H34.1
ICD-10 Finland
Central retinal artery occlusion
12.6
6.1
10
8
6BA02
NOMESCO Finland
NA
8.6
6.1
12
14
WX892
NOMESCO Finland
Monitored bed care
1.9
6.1
78
412
WW400
NOMESCO Finland
Plasmaferesis
10.1
6.0
11
11
N07AA03
ATC
distigmine; systemic
10.1
6.0
11
11
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
2.9
6.0
33
115

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
234
13
209.07
307.65
1.3
1.0
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
154
20
84.69
290.64
3.1
1.8
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
224
130
19.74
278.65
1.2
1.2
mg/l
41.9
35.2
0.91
174
105
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
220
125
20.11
276.36
1.1
1.0
mg/l
207.4
217.2
0.38
185
107
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
217
125
19.79
270.74
1.1
1.1
—
—
—
0
0
(4027681)
187
107
19.55
233.45
1.3
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
236
217
12.50
226.14
1.2
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
240
231
11.96
223.06
1.2
1.1
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
259
342
8.78
189.39
1.2
1.3
mg/l
406.0
467.3
1.63
242
324
(3044290) Cell count panel - Cerebral spinal fluid
231
276
9.55
182.78
1.2
1.5
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
436
1027
5.39
180.07
3.4
2.7
g/l
9.8
10.5
4.17
397
955
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
172
142
13.38
175.52
1.1
1.1
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
229
307
8.48
164.71
1.3
1.5
e6/l
354.5
1759.6
0.79
182
255
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
229
307
8.48
164.71
1.3
1.4
e6/l
9.1
13.0
0.50
172
248
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
141
98
15.62
158.65
1.1
1.0
u/l
1.0
1.0
0.91
56
51
(3011412) CD3 cells [#/volume] in Blood
145
112
14.08
153.67
3.6
2.4
e9/l
1.2
1.2
0.16
74
72
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
120
81
15.88
136.92
3.9
2.5
e9/l
0.2
0.2
0.78
104
75
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
120
83
15.50
135.12
3.9
2.4
e6/l
485.0
525.8
0.30
102
75
(42870588) Differential panel, method unspecified - Blood
916
4388
3.40
132.10
10.7
5.8
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
204
309
7.38
131.12
1.2
1.3
mmol/l
3.6
3.7
0.72
187
291
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
118
86
14.69
129.01
2.9
2.2
%
13.6
13.0
0.16
61
46
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
246
459
6.11
129.01
1.9
1.6
iu/ml
0.1
0.2
0.60
22
87
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
125
9
149.95
118.93
1.2
1.1
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
81
31
27.41
118.17
1.0
1.0
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
78
28
29.17
116.28
1.1
1.0
mg/g
4.7
5.6
0.93
73
28
(21494815) CD4 cells/100 lymphocytes in Specimen
114
100
12.16
111.32
2.5
2.1
%
48.6
32.9
—
34
10
(3022096) Basophils/100 leukocytes in Blood
1083
6201
3.11
106.83
12.1
5.9
%
0.7
0.7
3.87
1050
5822
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
349
1018
4.07
105.82
2.7
2.3
au/ml
27.8
21.7
0.36
13
78
(3006504) Eosinophils/100 leukocytes in Blood
1099
6434
3.06
102.41
12.1
5.8
%
3.0
2.8
2.13
1065
6028
(3006315) Basophils [#/volume] in Blood
1147
6877
3.12
102.32
12.4
5.8
e9/l
0.0
0.0
0.12
1059
6052
(3019069) Monocytes/100 leukocytes in Blood
1104
6482
3.06
102.28
12.2
6.1
%
9.0
8.2
18.78
1072
6126
(3001604) Monocytes [#/volume] in Blood
1141
6850
3.09
100.97
12.3
5.8
e9/l
0.6
0.5
1.02
1056
6032
(3002030) Lymphocytes/100 leukocytes in Blood
1118
6710
3.00
97.56
12.0
5.8
%
26.7
28.9
10.94
1081
6321
(3019198) Lymphocytes [#/volume] in Blood
1158
7084
3.06
97.55
12.2
5.8
e9/l
1.7
1.9
12.55
1079
6374
(3013115) Eosinophils [#/volume] in Blood
1161
7128
3.05
96.85
12.3
6.1
e9/l
0.2
0.2
0.40
1078
6381
(3016018) Differential panel - Cerebral spinal fluid
117
130
9.60
96.78
1.1
1.6
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
1106
6631
2.97
96.09
11.6
5.6
%
59.0
56.8
8.82
1072
6267
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
89
69
13.57
93.60
1.1
1.1
miu/ml
1667.0
1609.4
0.13
89
69
(3000060) B lymphocytes [#/volume] in Blood
69
33
21.76
92.27
3.2
2.2
e6/l
82.1
178.6
1.25
29
22
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
95
86
11.65
90.70
3.1
2.3
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
1213
7887
2.95
86.06
13.2
8.8
e9/l
3.8
4.0
3.50
1122
6970
(3023410) Appearance of Cerebral spinal fluid
108
140
8.18
78.88
1.2
1.7
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
91
98
9.76
76.88
4.2
2.4
e6/l
902.0
725.2
0.98
55
34
(3028026) IgM [Mass/volume] in Serum or Plasma
265
800
3.75
74.99
3.4
1.7
g/l
1.1
1.3
3.21
258
746
(3000850) Epithelial cells [#/volume] in Urine
524
2498
2.60
65.70
4.0
2.4
e6/l
4.7
7.2
5.32
481
2196
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
56
36
16.06
65.11
4.3
2.7
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
666
3642
2.38
61.02
5.2
2.9
e6/l
18.6
98.6
2.22
563
2741
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
901
5615
2.31
60.55
2.6
2.3
nmol/l
86.6
74.9
20.17
846
5185
(36304419) Bacteria [Presence] in Urine
617
3279
2.40
60.17
4.6
2.8
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
764
4455
2.31
60.00
5.9
3.4
e6/l
93.7
83.7
0.13
595
2981
(3026782) Osmolality of Urine
486
2322
2.54
59.83
3.6
2.6
mosm/kgh2o
536.9
545.5
0.37
446
1993
(21494814) CD8 cells/100 lymphocytes in Specimen
55
41
13.84
58.96
2.2
2.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
614
3296
2.36
58.11
4.8
2.8
e6/l
0.1
0.4
8.27
511
2433
(3021589) Normoblasts [#/volume] in Blood
940
6088
2.24
55.91
13.8
8.4
e9/l
0.0
0.0
0.70
827
5006
(3037467) Urinalysis macro (dipstick) panel - Urine
1257
9431
2.33
48.78
7.1
3.9
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
187
598
3.39
47.61
1.9
2.1
u/l
38.2
39.9
0.57
182
550
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
57
66
8.91
45.42
1.4
1.4
%
78.2
77.7
—
6
9
(3031040) Bacteria [#/volume] in Urine by Automated count
1193
8957
2.15
43.19
8.0
3.9
e6/l
74.4
2178.5
1.71
21
108
(3002179) Metamyelocytes/100 leukocytes in Blood
249
1005
2.74
41.91
5.2
4.1
%
0.4
0.6
1.19
51
219
(3023511) Choriogonadotropin [Units/volume] in Urine
171
560
3.29
41.75
1.7
1.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
620
3726
2.05
41.08
4.1
2.6
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
783
5135
1.99
40.33
4.6
4.5
g/l
37.0
36.4
2.33
735
4804
(3021440) Promyelocytes/100 leukocytes in Blood
251
1047
2.64
39.45
5.5
4.3
%
0.0
0.2
2.22
62
270
(3017181) Myelocytes/100 leukocytes in Blood
259
1103
2.59
39.01
5.4
4.2
%
0.5
1.0
2.68
63
298
(3025159) Blasts/100 leukocytes in Blood
238
989
2.64
37.61
5.5
4.3
%
0.0
0.8
0.93
56
228
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
101
252
4.20
36.72
4.5
3.9
%
59.8
57.0
1.34
101
252
(3030905) Polymorphonuclear cells [#/volume] in Blood
99
245
4.23
36.38
4.4
3.6
e9/l
3.6
4.1
2.34
99
245
(3035350) Ketones [Presence] in Urine by Test strip
941
6746
1.90
35.46
5.6
3.3
estimate
0.0
0.0
0.50
243
1258
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
40
41
9.97
34.84
1.3
1.1
%
18.3
18.0
—
6
5
(3009261) Glucose [Presence] in Urine by Test strip
946
6827
1.89
34.55
5.6
3.3
estimate
0.0
0.0
1.06
246
1240
(3021879) Hepatitis B virus core Ab [Presence] in Serum
280
1315
2.36
33.81
1.3
1.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
936
6761
1.87
33.78
7.4
4.5
estimate
0.0
0.0
0.37
245
1283
(3013826) Glucose [Moles/volume] in Serum or Plasma
985
7285
1.85
32.39
4.3
4.4
mmol/l
6.3
6.5
2.98
927
6682
(40758558) Short blood count panel - Blood
542
3417
1.87
29.03
9.2
6.5
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
49
84
5.98
27.52
4.0
3.0
%
51.1
44.0
1.22
24
25
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
886
6569
1.74
26.69
5.9
5.7
umol/l
10.0
10.6
0.82
840
6223
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
35
44
8.10
26.06
1.2
1.1
ng/l
133.4
62.7
—
12
7
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1225
10036
1.82
25.31
7.8
7.0
u/l
74.7
74.8
0.04
1163
9464
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
345
1966
1.95
24.60
4.6
2.5
e6/l
0.9
1.3
0.77
212
1059
(3018677) aPTT in Platelet poor plasma by Coagulation assay
307
1707
1.98
23.42
2.0
2.1
s
29.4
29.5
0.08
297
1649
(3017143) Hepatitis C virus Ab [Presence] in Serum
346
2011
1.91
23.12
1.5
1.6
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
324
1851
1.93
22.77
4.7
2.6
e6/l
3.3
3.4
0.02
190
949
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
107
382
2.92
22.35
1.6
2.1
mg/l
9.1
10.9
2.01
101
357
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
22
18
12.37
22.10
1.0
1.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
28
34
8.36
21.41
2.2
2.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
511
3411
1.72
21.26
9.1
4.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
463
3043
1.72
20.21
4.7
3.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
224
1178
2.04
19.78
7.0
3.4
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
1192
10069
1.64
17.94
4.2
3.9
mm/h
10.3
10.4
0.05
1111
9428
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1539
14030
2.19
17.55
16.3
11.7
mg/l
20.1
20.5
0.19
1233
10894
(3015377) Calcium [Moles/volume] in Serum or Plasma
579
4158
1.60
17.37
2.4
3.2
mmol/l
2.3
2.3
0.27
517
3739
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
31
55
5.72
16.83
1.2
2.1
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1520
13848
2.06
16.47
15.3
12.3
mmol/l
139.7
139.6
0.57
1493
13493
(3023103) Potassium [Moles/volume] in Serum or Plasma
1523
13891
2.06
16.36
15.4
12.4
mmol/l
3.9
3.9
1.98
1488
13508
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
495
3489
1.59
15.75
2.2
2.1
u/l
121.6
186.8
2.22
466
3315
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
147
729
2.11
15.09
2.7
1.8
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
449
3124
1.60
14.96
1.7
1.7
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
455
3189
1.59
14.65
4.6
3.5
%
97.9
95.1
1.96
449
3092
(3007164) IgA [Mass/volume] in Serum or Plasma
441
3071
1.59
14.59
2.2
1.4
g/l
2.0
2.3
2.76
311
1967
(3041096) Erythrocytes [Presence] in Urine by Automated
530
3890
1.53
13.74
5.6
2.9
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
584
4377
1.51
13.71
7.2
7.1
inr
1.1
1.1
1.06
200
1389
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
183
1024
1.88
13.32
2.9
2.2
u/l
1472.4
5571.8
2.91
45
418
(3052851) Hemolysis interference index of Serum or Plasma
83
347
2.46
12.76
2.3
3.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
488
3578
1.51
12.49
7.1
3.6
estimate
0.0
0.0
1.28
243
1256
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1584
14871
2.20
12.42
15.2
9.1
u/l
26.2
25.8
0.40
1551
14453
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
676
5309
1.46
12.19
6.2
3.3
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
149
804
1.94
12.09
1.8
2.7
g/l
68.5
67.4
1.02
139
744
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1143
9943
1.47
11.75
4.3
2.9
u/l
44.2
40.3
0.82
1092
9457
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1425
13010
1.64
11.54
14.2
10.1
ml/min/173m2
92.1
88.5
8.53
1212
10656
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
39
116
3.42
11.13
1.2
1.8
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
92
428
2.22
11.11
1.6
1.7
titre
200.0
158.7
—
7
15
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
727
5868
1.42
10.94
6.1
6.2
mmol/l
1.2
1.2
0.66
600
4982
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
660
5240
1.43
10.87
5.3
5.5
mmol/l
1.2
1.2
0.07
604
4789
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
23
47
4.95
10.75
1.0
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
108
544
2.05
10.65
1.5
1.3
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
44
148
3.03
10.31
1.6
1.4
g/l
0.3
0.4
0.67
31
103
(3028192) IgG subclass 2 [Mass/volume] in Serum
44
148
3.03
10.31
1.6
1.4
g/l
2.7
2.9
0.36
32
103
(3018418) pH of Serum or Plasma
464
3480
1.46
10.26
4.2
3.7
ph
7.4
7.4
0.93
101
655
(3027135) IgG subclass 1 [Mass/volume] in Serum
44
149
3.01
10.19
1.6
1.4
g/l
5.9
6.8
0.97
32
105
(46235355) HIV 1 and 2 tests - Meaningful Use set
497
3789
1.44
10.04
1.9
1.9
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
60
243
2.52
9.92
1.6
1.8
g/l
0.5
0.8
2.14
46
184
(4062490)
44
153
2.93
9.74
1.6
1.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
594
4704
1.41
9.62
3.9
3.1
u/l
28.7
30.0
0.58
568
4492
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
27
69
3.96
9.60
1.0
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
77
355
2.23
9.54
1.4
1.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1333
12125
1.49
9.52
22.4
14.1
%
13.4
13.5
2.34
1315
11876
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
27
71
3.85
9.24
1.0
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
21
46
4.61
9.07
1.0
1.0
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
37
124
3.03
8.76
3.9
3.5
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
548
4337
1.39
8.71
3.3
3.0
ng/l
40.2
46.6
0.17
311
2421
(3037522) Nuclear Ab [Titer] in Serum
294
2105
1.48
8.03
1.5
1.4
titre
476.6
550.0
0.47
70
434
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
17
35
4.90
7.89
1.2
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
17
35
4.90
7.89
1.2
1.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
219
1491
1.54
7.59
3.1
2.6
umol/l
6.1
7.4
0.63
184
1277
(3023368) Bacteria identified in Blood by Culture
379
2883
1.41
7.43
6.0
4.1
—
—
—
0
0
(3013512) EKG study
414
3220
1.38
7.07
3.5
3.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
23
66
3.52
7.00
1.2
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
88
486
1.86
6.72
2.0
2.1
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
42
176
2.42
6.56
2.4
3.1
%
0.7
1.2
1.48
37
145
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1395
13099
1.39
5.82
5.4
4.8
mu/l
1.7
2.0
1.09
1312
12311
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
570
4761
1.30
5.79
1.9
1.8
pmol/l
99.6
97.8
0.34
291
2560
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
15
37
4.08
5.63
1.3
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
15
37
4.08
5.63
1.3
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
150
1005
1.54
5.59
2.1
2.5
e9/l
4.1
4.1
0.14
131
843
(3003458) Phosphate [Moles/volume] in Serum or Plasma
199
1414
1.46
5.59
4.7
5.5
mmol/l
1.1
1.0
0.42
180
1319
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
14
33
4.27
5.56
1.1
1.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
244
1803
1.41
5.55
1.9
1.8
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
15
38
3.97
5.44
1.3
1.1
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
251
1873
1.40
5.39
3.3
3.3
mmol/l
0.8
0.8
0.44
240
1766
(40761511) CBC panel - Blood by Automated count
1547
14851
1.55
5.31
15.0
10.8
—
—
—
0
0
(3012501) Base excess in Blood by calculation
49
241
2.06
5.29
3.8
3.0
mmol/l
1.6
2.4
1.92
26
153
(3004588) Protein electrophoresis panel - Serum or Plasma
106
664
1.64
5.26
1.9
2.3
—
—
—
0
0
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
5
0
+∞
5.21
1.4
0.0
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
12
27
4.47
5.04
1.5
1.0
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
96
596
1.65
4.95
1.6
1.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1240
13177
0.77
4.88
3.4
3.5
mmol/l
1.3
1.3
0.30
1156
12385
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
172
1221
1.46
4.86
3.5
2.3
u/l
35.3
40.7
0.52
142
1028
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
137
939
1.50
4.63
4.0
3.2
mmol/l
1.2
1.2
0.82
124
809
(3010421) pH of Blood
54
290
1.89
4.59
3.7
3.0
ph
7.4
7.4
0.93
46
237
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
26
106
2.48
4.39
1.1
1.5
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
252
1945
1.35
4.37
1.8
1.7
nmol/l
1164.1
1177.1
0.08
191
1517
(3007461) Platelets [#/volume] in Blood
1622
15820
1.80
4.36
26.7
17.2
e9/l
261.8
260.8
0.28
1598
15495
(3024731) MCV [Entitic volume]
1623
15833
1.81
4.36
26.6
17.1
fl
90.8
90.4
3.60
1607
15669
(3035941) MCH [Entitic mass]
1623
15835
1.80
4.33
26.6
17.1
pg
30.2
30.1
0.76
1607
15669
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
480
4043
1.26
4.32
2.6
2.5
u/l
59.0
56.1
0.31
446
3772
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
164
1181
1.43
4.31
3.6
2.8
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
1623
15838
1.80
4.28
26.7
17.2
e12/l
4.5
4.5
0.57
1595
15482
(3010813) Leukocytes [#/volume] in Blood
1623
15841
1.79
4.23
26.7
17.2
e9/l
6.6
6.7
1.52
1593
15480
(3027945) Reticulocytes/100 erythrocytes in Blood
154
1101
1.44
4.21
3.7
2.6
%
1.6
1.8
1.55
138
985
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
210
1586
1.37
4.19
2.2
2.3
%
21.8
23.5
1.12
175
1366
(3000963) Hemoglobin [Mass/volume] in Blood
1623
15845
1.78
4.17
26.8
17.3
g/l
135.3
135.4
0.07
1606
15675
(3042631) Mycobacterium sp identified in Specimen
28
122
2.32
4.11
3.9
2.7
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
20
74
2.72
4.09
1.4
3.4
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
64
381
1.71
3.92
1.3
1.3
titre
74.4
86.1
—
9
38
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
56
321
1.77
3.91
2.2
1.6
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
28
126
2.24
3.84
1.2
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
25
107
2.36
3.84
1.8
3.2
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
156
1138
1.41
3.83
3.0
4.5
u/l
222.4
247.4
1.55
148
1082
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1305
13682
0.79
3.75
3.7
3.8
mmol/l
1.5
1.5
0.64
1207
12896
(3004789) Transferrin [Mass/volume] in Serum or Plasma
224
1740
1.33
3.72
2.2
2.2
g/l
2.4
2.4
0.05
203
1623
(3028433) Virus identified in Specimen by Culture
14
46
3.06
3.53
1.0
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
41
222
1.87
3.47
2.7
2.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
162
1213
1.37
3.43
1.8
1.7
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
118
836
1.44
3.43
1.8
1.7
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
173
1312
1.36
3.38
6.3
6.9
mmol/l
105.2
104.4
1.41
168
1285
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
9
18
5.02
3.37
1.2
1.0
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
7
10
7.02
3.36
1.0
1.2
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
145
1070
1.39
3.36
2.5
2.3
g/l
0.2
0.2
0.03
139
1014
(21494755) Public health laboratory ask at order entry panel
147
1954
0.73
3.34
1.3
1.3
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
31
155
2.02
3.31
2.2
1.3
mmol/l
62.8
64.6
0.08
26
133
(3004616) Nuclear Ab [Presence] in Serum
33
169
1.97
3.30
1.2
1.3
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
65
409
1.61
3.28
1.4
2.1
g/l
1.5
1.4
0.29
55
359
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
22
96
2.31
3.27
1.2
1.2
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
6
7
8.60
3.26
1.2
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
9
19
4.76
3.24
1.2
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
45
257
1.77
3.24
1.1
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
40
221
1.83
3.20
1.2
1.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
36
193
1.88
3.17
1.9
1.5
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
29
144
2.03
3.16
1.3
1.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
319
2652
1.25
3.13
1.6
1.5
nmol/l
19.7
20.6
0.55
276
2331
(3022948) Iron [Moles/volume] in Serum or Plasma
238
1912
1.29
3.10
2.3
2.2
umol/l
13.0
14.0
1.19
219
1768
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
6
8
7.52
3.05
1.2
1.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
163
2102
0.75
3.03
1.4
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
381
3243
1.23
3.00
1.8
1.7
mg/l
0.8
1.0
1.81
282
2409
(40768443) Skin Pathology biopsy report
79
532
1.51
2.99
1.2
1.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
318
2657
1.24
2.98
2.5
2.9
ng/l
978.3
960.6
0.04
266
2206
(3023520) Reticulocytes [#/volume] in Blood
108
775
1.42
2.96
2.3
2.6
e9/l
66.5
72.7
1.28
92
584
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1319
13736
0.81
2.95
3.7
3.9
mmol/l
4.8
4.8
0.33
1234
13003
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
8
17
4.72
2.92
1.0
1.5
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1200
11352
1.20
2.88
4.5
4.2
pmol/l
14.6
14.5
0.82
1114
10589
(3032352) Blasts [#/volume] in Cerebral spinal fluid
6
9
6.69
2.87
4.3
3.7
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
80
1147
0.68
2.85
1.7
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
160
1233
1.33
2.84
1.8
1.8
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
122
903
1.38
2.81
6.8
7.5
mmol/l
8.5
8.3
0.11
115
867
(3036481) Cortisol [Moles/volume] in Serum or Plasma
174
1360
1.31
2.80
2.8
2.0
nmol/l
364.7
372.4
0.12
162
1259
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
262
2161
1.25
2.75
3.0
3.3
ng/l
472.9
378.3
0.15
150
1373
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
49
303
1.64
2.70
2.4
2.9
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
22
105
2.11
2.69
1.1
1.1
—
43.2
—
0
5
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
19
4.23
2.68
1.3
1.1
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
56
359
1.58
2.67
1.5
2.2
g/l
3.1
3.1
0.09
42
286
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
10
265
0.37
2.66
2.0
3.6
u/ml
200.1
26.9
—
10
257
(3007853) Bacteria identified in Skin by Aerobe culture
190
1515
1.29
2.64
2.2
1.6
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
22
106
2.09
2.63
1.1
1.2
—
81.0
—
0
9
(3034891) Synovial lining cells/100 cells in Synovial fluid
13
49
2.67
2.62
1.8
1.3
%
—
6.3
—
0
12
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
39
230
1.71
2.57
1.3
1.7
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
62
412
1.52
2.54
1.1
1.3
u/ml
3.6
8.8
—
8
74
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
35
586
0.59
2.53
1.7
1.7
—
—
—
0
0
(4024509)
20
95
2.12
2.49
1.3
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
96
699
1.40
2.47
1.5
1.5
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
24
123
1.97
2.46
1.5
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
24
123
1.97
2.46
1.5
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
24
123
1.97
2.46
1.5
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1343
13908
0.83
2.45
4.0
4.2
mmol/l
2.8
2.9
0.32
1240
13082
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
24
124
1.95
2.41
1.5
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
24
124
1.95
2.41
1.5
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
24
124
1.95
2.41
1.5
1.1
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
12
5.01
2.40
1.3
1.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
57
378
1.53
2.38
1.5
2.2
g/l
3.5
3.8
1.12
42
279
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
57
378
1.53
2.38
1.5
2.2
g/l
7.6
7.4
0.39
44
296
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
57
378
1.53
2.38
1.5
2.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
14
58
2.43
2.37
1.1
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
28
154
1.83
2.34
1.7
1.5
—
—
—
0
0
(3044889) 12 lead EKG panel
961
8999
1.16
2.33
3.2
3.2
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
44
276
1.61
2.33
3.0
5.4
iu/ml
1664.4
273.1
—
5
36
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
37
222
1.68
2.32
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
37
222
1.68
2.32
1.3
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
194
1581
1.26
2.28
1.6
1.4
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
11
41
2.69
2.28
1.0
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
151
1891
0.78
2.27
1.6
1.9
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
111
843
1.34
2.22
2.4
1.6
mu/l
343.6
304.2
0.59
98
754
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
19
93
2.05
2.21
1.7
1.5
%
33.2
35.9
—
9
56
(3006922) Hepatitis E virus Ab [Presence] in Serum
20
100
2.01
2.21
1.0
1.0
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
12
48
2.51
2.18
2.2
3.1
umol/l
23.3
31.2
—
7
39
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
43
658
0.64
2.17
1.5
1.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
64
445
1.46
2.15
1.2
1.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
59
405
1.47
2.12
1.1
1.3
u/ml
2.1
2.3
—
5
47
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
19
96
1.99
2.05
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
19
96
1.99
2.05
1.0
1.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
13
56
2.33
2.05
1.0
1.2
—
—
—
0
0
(4198724)
16
76
2.12
2.02
1.2
1.9
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
22
118
1.88
2.02
1.3
1.8
pg
32.9
31.9
0.43
22
118
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
107
1375
0.76
1.99
1.4
1.5
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
48
321
1.51
1.97
1.5
2.3
g/l
0.3
0.7
0.61
43
295
(3005322) IgE [Units/volume] in Serum or Plasma
135
1074
1.28
1.96
1.4
1.3
u/ml
367.0
212.9
0.35
123
996
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
133
1659
0.78
1.96
1.7
1.6
—
—
—
0
0
(3000012) Reticulocyte production index
12
51
2.36
1.95
1.5
1.6
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
5
11
4.56
1.94
1.0
1.0
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
48
698
0.68
1.92
1.3
1.7
mg/l
3.2
3.5
0.16
29
480
(3008536) Aspergillus sp Ab [Presence] in Serum
7
22
3.19
1.88
2.1
2.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
12
53
2.27
1.80
3.1
2.8
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
8
29
2.77
1.79
10.3
4.8
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
128
1025
1.27
1.79
3.3
3.4
pmol/l
4.5
4.6
0.04
114
919
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
52
362
1.45
1.78
1.1
1.3
u/ml
40.5
41.8
—
6
39
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
13
60
2.18
1.78
1.0
1.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
13
60
2.18
1.78
1.1
1.1
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
17
88
1.94
1.75
1.2
1.3
u/l
6.4
6.9
0.18
11
74
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
6
18
3.34
1.74
1.2
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
21
117
1.80
1.74
1.0
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
53
740
0.71
1.72
1.5
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
332
2935
1.16
1.69
6.1
3.5
kg/l
1.0
1.0
0.22
45
407
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
36
235
1.54
1.68
2.3
2.4
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
50
350
1.44
1.68
1.6
2.2
g/l
10.3
10.3
0.02
43
304
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
42
284
1.49
1.68
1.6
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
40
268
1.50
1.67
1.5
1.5
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
33
501
0.65
1.67
1.5
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
65
478
1.37
1.66
2.2
1.9
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
33
212
1.57
1.65
2.5
2.2
%
14.9
16.3
0.87
13
101
(3049717) Cytology report of Urine Cyto stain
46
318
1.46
1.65
2.1
2.3
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
5
14
3.58
1.61
1.0
1.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
361
3222
1.15
1.61
2.3
2.1
mg/l
3.0
2.8
0.49
315
2777
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
39
262
1.50
1.61
1.2
1.2
u/ml
2.7
4.5
0.59
15
84
(1617658) Protocol used for examination of sentinel lymph nodes
5
134
0.37
1.61
1.0
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
59
430
1.39
1.60
1.9
1.7
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
90
700
1.30
1.60
1.2
1.3
miu/ml
197.0
225.1
0.29
31
355
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
43
296
1.46
1.59
1.6
2.3
g/l
39.9
38.3
0.83
38
265
(40768804) Tissue Pathology biopsy report
619
5731
1.13
1.58
2.2
2.0
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
7
26
2.70
1.58
1.1
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
233
2016
1.18
1.55
2.1
2.4
ug/g
121.8
109.9
0.20
168
1598
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
7
27
2.60
1.51
1.0
1.0
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
287
2531
1.16
1.51
1.7
1.6
pmol/l
434.2
35251569.9
2.87
250
2190
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
398
3594
1.14
1.50
1.3
1.3
u/ml
1.6
1.6
0.01
110
993
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
17
94
1.82
1.47
2.2
2.3
u/field
5.0
2.6
—
7
50
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
8
167
0.48
1.47
1.1
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
26
163
1.60
1.46
1.4
1.4
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
83
649
1.29
1.44
3.7
3.1
kpa
5.3
5.2
0.58
78
612
(3022145) Colonoscopy Study observation
170
1441
1.20
1.44
1.3
1.3
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
5
16
3.13
1.44
1.2
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
75
961
0.77
1.42
1.3
1.4
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
38
263
1.46
1.39
2.0
2.8
nmol/l
1.0
0.9
0.52
31
221
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
29
2.42
1.39
1.4
3.6
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
29
2.42
1.39
1.4
3.6
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
18
104
1.74
1.37
1.1
1.1
nmol/l
2.4
0.6
—
6
17
(3017509) Phencyclidine [Presence] in Urine
6
23
2.61
1.37
1.5
1.1
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
0
39
0.00
1.33
0.0
2.5
—
707.4
—
0
33
(3009343) pH of Capillary blood
81
639
1.28
1.33
3.7
3.1
ph
7.4
7.4
—
10
81
(1761868) Lipid panel - Serum or Plasma
516
5567
0.89
1.33
2.5
2.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
117
964
1.23
1.33
6.0
3.2
—
—
—
0
0
(4211845)
12
61
1.97
1.33
3.1
2.8
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
22
136
1.63
1.32
1.9
1.7
%
50.1
53.6
0.15
12
89
(3009214) Lutropin [Units/volume] in Serum or Plasma
68
526
1.31
1.30
1.4
1.3
u/l
9.3
10.9
0.48
57
432
(3021788) Differential panel - Synovial fluid
30
201
1.50
1.30
1.8
1.7
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
70
892
0.78
1.29
1.5
1.5
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
8
34
2.36
1.29
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
8
34
2.36
1.29
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
8
34
2.36
1.29
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
8
34
2.36
1.29
1.0
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1065
11046
0.90
1.26
3.6
3.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
62
476
1.31
1.26
1.2
1.3
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
37
261
1.43
1.25
1.2
1.2
u/ml
2.7
5.0
1.32
17
111
(3000330) Specific gravity of Urine by Test strip
74
583
1.28
1.24
5.0
3.0
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
8
36
2.23
1.24
2.0
2.1
ug/l
44.4
50.7
—
8
36
(3000991) Gas panel - Venous blood
104
858
1.23
1.19
7.0
8.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
60
463
1.31
1.19
3.8
3.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
18
109
1.66
1.19
1.1
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
105
868
1.22
1.18
3.3
2.5
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
20
309
0.64
1.16
2.1
2.3
umol/l
4.4
4.8
0.13
14
228
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
237
2106
1.15
1.15
2.5
2.7
mmol/l
2.4
2.4
0.36
206
1846
(3042936) Bacteria identified in Isolate by Culture
195
1709
1.16
1.15
2.5
1.9
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
5
111
0.45
1.13
1.0
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
30
2.34
1.12
1.0
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
299
2704
1.13
1.11
1.3
1.3
iu/ml
27.6
27.7
0.00
72
855
(3048929) Epstein Barr virus Ab [Presence] in Serum
71
566
1.27
1.11
1.2
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
31
218
1.43
1.09
1.4
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
208
1840
1.15
1.09
1.2
1.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
77
622
1.25
1.08
3.8
3.0
mmol/l
1.8
1.6
0.14
57
450
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
29
202
1.44
1.08
1.1
1.9
—
1210.0
—
0
8
(3017446) Testosterone [Moles/volume] in Serum or Plasma
91
750
1.23
1.07
2.5
2.2
nmol/l
11.6
11.9
0.10
81
671
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
28
194
1.45
1.07
1.4
1.4
—
—
—
0
0
(4146454)
16
97
1.66
1.06
2.6
2.5
—
—
—
0
0
(3019225) pH of Specimen
133
1139
1.18
1.05
4.1
3.7
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
29
203
1.44
1.05
2.6
2.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
54
420
1.30
1.04
3.8
3.2
g/l
0.3
0.3
0.16
25
160
(36660697) Celiac disease serology panel - Serum
145
1253
1.17
1.04
1.2
1.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
16
98
1.64
1.03
1.0
1.2
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
59
741
0.79
1.02
1.3
1.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
141
1219
1.17
1.01
13.4
18.3
inr
1.1
1.2
0.31
23
191
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
59
740
0.79
1.01
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
59
739
0.79
1.00
1.3
1.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
132
1137
1.17
0.99
5.2
8.5
mmol/l
1.0
1.0
0.09
94
885
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
59
738
0.79
0.99
1.3
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
29
206
1.41
0.99
1.3
1.1
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
45
344
1.32
0.99
1.3
1.4
u/l
24.9
23.4
0.14
38
293
(3002032) Base excess in Venous blood by calculation
112
953
1.19
0.97
4.9
3.4
mmol/l
2.2
1.9
0.38
96
763
(3044007) Cell count panel - Peritoneal fluid
0
30
0.00
0.97
0.0
2.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
20
132
1.52
0.97
1.3
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
15
92
1.64
0.97
1.9
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
54
425
1.28
0.96
1.2
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
367
3389
1.11
0.95
1.5
1.5
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
0
32
0.00
0.95
0.0
2.4
—
4659.2
—
0
19
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
26
183
1.43
0.94
1.2
1.3
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
22
316
0.69
0.93
1.1
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
17
109
1.57
0.93
1.4
1.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
98
1155
0.84
0.93
1.4
1.4
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
6
27
2.23
0.93
2.7
1.4
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
34
252
1.36
0.92
2.1
2.8
mmol/l
25.1
24.8
0.12
27
228
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
6
28
2.15
0.91
1.5
1.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
6
28
2.15
0.91
1.0
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
39
297
1.32
0.89
1.4
1.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
448
4193
1.09
0.88
2.8
2.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
8
42
1.91
0.88
3.7
2.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
10
56
1.79
0.88
1.9
1.4
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
10
56
1.79
0.88
1.3
1.2
—
72.2
—
0
9
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
66
802
0.82
0.87
1.3
1.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
24
169
1.43
0.87
2.2
2.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
116
1339
0.86
0.87
1.8
1.8
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
299
2747
1.11
0.87
2.0
2.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
11
64
1.72
0.86
1.1
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
8
44
1.82
0.86
2.8
2.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
71
587
1.22
0.85
1.9
1.8
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
35
265
1.33
0.84
3.3
3.6
mg/l
39.6
28.6
0.52
26
216
(3051593) INR in Capillary blood by Coagulation assay
6
31
1.94
0.84
1.0
8.5
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
20
137
1.47
0.84
2.3
2.1
mg/l
19.7
23.2
—
7
41
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
10
57
1.76
0.83
1.9
1.4
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
19
272
0.70
0.82
1.0
1.0
u/ml
2.8
2.1
—
7
140
(3016502) Oxygen saturation in Arterial blood
115
1000
1.16
0.80
5.4
9.1
%
96.6
96.1
0.73
110
967
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
61
501
1.23
0.79
5.0
3.5
mmol/l
24.6
24.3
0.33
56
451
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
0
24
0.00
0.79
0.0
1.0
—
1.6
—
0
16
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
0
24
0.00
0.79
0.0
1.0
—
0.0
—
0
16
(44806420)
0
25
0.00
0.79
0.0
2.7
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
38
295
1.29
0.78
2.5
1.9
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
38
295
1.29
0.78
1.8
1.8
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
267
2453
1.11
0.78
2.0
2.0
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
26
0.00
0.78
0.0
7.5
—
—
—
0
0
(1002224) Polysomnography panel
59
714
0.82
0.77
1.1
1.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
27
360
0.75
0.77
1.0
1.1
u/ml
5.9
6.3
0.06
13
190
(3027801) Oxygen [Partial pressure] in Arterial blood
130
1146
1.15
0.76
5.3
8.4
kpa
13.1
12.9
0.15
124
1097
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
130
1146
1.15
0.76
5.3
8.4
kpa
5.0
5.1
0.67
124
1094
(3001556) Androgen free Index in Serum or Plasma
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
66
550
1.21
0.76
1.7
1.8
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
9
53
1.70
0.75
1.6
3.2
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
11
67
1.65
0.75
1.1
1.1
iu/ml
125.1
212.5
1.21
11
67
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
11
67
1.65
0.75
2.0
1.7
nmol/l
1.9
5.3
—
6
51
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
13
83
1.57
0.75
1.6
1.5
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
22
158
1.40
0.74
1.4
1.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
30
391
0.76
0.74
1.2
1.3
—
—
—
0
0
(4268621)
25
184
1.36
0.74
2.5
2.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
19
133
1.43
0.73
1.1
1.0
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
7
38
1.85
0.73
1.3
1.1
—
83.3
—
0
11
(3047352) Trisomy 18 risk [Likelihood] in Fetus
50
611
0.81
0.73
1.3
1.4
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
7
39
1.80
0.72
1.3
1.2
—
71.5
—
0
11
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
9
56
1.61
0.72
1.7
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
9
57
1.58
0.71
1.7
1.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
178
1963
0.90
0.71
1.8
1.8
%
1.5
1.4
0.94
162
1766
(3005033) Fetal Nuchal fold Thickness US
50
608
0.82
0.70
1.3
1.4
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
34
265
1.29
0.70
3.4
3.6
mg/l
53.7
71.7
0.27
25
217
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
7
41
1.71
0.70
1.1
2.2
umol/l
16.2
16.8
—
7
41
(43055514) Macroprolactin [Presence] in Serum or Plasma
9
58
1.55
0.69
1.6
1.4
—
—
—
0
0
(3034426) Prothrombin time (PT)
9
58
1.55
0.69
1.7
1.3
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
26
342
0.76
0.69
1.0
1.1
u/ml
0.3
1.3
—
7
143
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
17
118
1.45
0.69
1.4
1.4
titre
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
7
118
0.59
0.68
1.3
1.6
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
108
950
1.15
0.67
5.2
6.9
mmol/l
1.2
1.3
1.19
103
915
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
36
285
1.27
0.67
3.1
3.5
u/ml
0.3
0.4
0.53
21
153
(3023419) Bacteria identified in Sputum by Culture
19
136
1.40
0.67
3.1
2.7
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
38
303
1.26
0.66
2.1
1.7
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
29
373
0.77
0.66
1.7
1.5
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
5
28
1.79
0.66
1.0
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
190
1734
1.11
0.65
1.3
1.2
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
51
422
1.22
0.65
1.9
2.0
iu/l
5.7
4.6
0.16
17
162
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
33
260
1.27
0.64
1.0
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
233
2152
1.10
0.64
4.8
4.3
ug/l
2.0
2.3
0.42
211
1943
(40760888) Immunoglobulin light chains.free panel - Serum
26
200
1.30
0.60
3.2
3.9
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
8
51
1.57
0.60
1.0
1.3
—
—
—
0
0
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.0
—
1.4
—
0
14
(3052592) Norovirus Ag [Presence] in Stool
0
20
0.00
0.60
0.0
1.5
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
30
236
1.28
0.60
1.1
1.1
iu/ml
23.8
2033.4
—
6
64
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
0
22
0.00
0.59
0.0
1.0
—
0.0
—
0
15
(3043238) Trisomy 21 risk [Likelihood] in Fetus
53
627
0.84
0.59
1.3
1.5
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
23
0.00
0.58
0.0
3.5
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
23
0.00
0.58
0.0
7.8
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
23
0.00
0.58
0.0
1.7
—
1.2
—
0
23
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
65
1.54
0.55
1.9
1.4
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
13
90
1.45
0.55
2.5
2.1
—
1.9
—
0
8
(44816559) Phosphatidylethanol [Mass/volume] in Blood
26
328
0.79
0.54
1.0
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
61
525
1.17
0.54
6.5
12.2
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
9
62
1.45
0.53
2.7
2.6
umol/l
54.6
50.3
—
9
51
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
16
117
1.37
0.52
1.3
1.7
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
44
369
1.20
0.52
2.5
2.7
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
6
40
1.50
0.51
1.3
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
411
4298
0.94
0.48
1.6
1.6
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
29
235
1.24
0.48
2.0
3.1
umol/l
29.0
31.9
0.67
24
196
(3017315) Amylase [Enzymatic activity/volume] in Urine
11
76
1.45
0.48
1.1
1.1
u/l
392.6
378.3
0.03
11
68
(3001122) Ferritin [Mass/volume] in Serum or Plasma
718
6970
1.05
0.48
2.8
2.8
ug/l
98.6
90.5
0.58
681
6572
(3036489) Thrombin time
60
522
1.15
0.48
2.2
2.1
s
20.6
20.9
0.23
54
453
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
10
143
0.70
0.47
1.1
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
74
655
1.14
0.47
4.2
5.9
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
20
155
1.29
0.47
1.5
1.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
40
337
1.19
0.46
1.2
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
24
191
1.26
0.46
1.2
1.7
—
—
—
0
0
(3011648) Oxygen content in Venous blood
11
77
1.43
0.45
2.5
2.1
%
13.1
10.9
0.99
11
77
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
91
822
1.11
0.43
2.1
2.2
ug/l
6.3
7.3
0.30
72
735
(3029396) Erythrocyte agglutination [Presence] in Blood
8
56
1.43
0.42
2.1
3.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
18
140
1.29
0.42
2.2
1.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
138
1276
1.09
0.41
1.2
1.2
iu/ml
220.1
146.2
0.83
51
512
(1761482) Bacteria [#/volume] in Urine by Culture
33
277
1.20
0.41
8.5
3.7
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
11
79
1.39
0.40
2.8
1.2
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
17
0.00
0.40
0.0
9.7
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
19
150
1.27
0.40
1.3
1.4
pmol/l
248.3
353.2
1.82
11
112
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
328
3134
1.06
0.40
2.8
2.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
8
61
1.31
0.39
1.0
1.3
—
—
—
0
0
(3027035) Albumin [Mass/time] in 24 hour Urine
0
19
0.00
0.39
0.0
1.2
—
57.9
—
0
5
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
20
160
1.25
0.38
1.1
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
23
188
1.23
0.37
1.3
1.3
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
40
461
0.86
0.37
1.1
1.1
u/ml
0.9
4.1
—
5
72
(3045424) Erythrocytes [Presence] in Urine
26
216
1.21
0.37
1.3
1.4
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
10
72
1.39
0.37
1.0
1.5
nmol/l
140.7
137.5
—
10
72
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
373
3587
1.05
0.36
1.7
1.6
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1241
12559
0.95
0.36
22.3
14.7
g/l
332.3
332.6
0.62
1233
12468
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
160
1705
0.93
0.35
1.9
1.9
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
6
42
1.43
0.35
1.0
1.4
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
6
43
1.40
0.35
6.2
3.1
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
19
154
1.24
0.34
1.2
1.4
mmol/l
10.9
12.3
—
7
28
(4034850)
39
445
0.87
0.33
7.8
9.0
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
6
47
1.28
0.32
1.3
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
6
47
1.28
0.32
1.3
1.3
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
6
47
1.28
0.32
1.0
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
57
633
0.90
0.32
1.8
2.0
—
—
—
0
0
(44790049)
13
165
0.79
0.32
1.3
1.5
—
—
—
0
0
(44790047)
13
165
0.79
0.32
1.3
1.5
—
—
—
0
0
(44790048)
13
165
0.79
0.32
1.3
1.5
—
—
—
0
0
(44806118)
13
165
0.79
0.32
1.3
1.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
16
128
1.25
0.32
1.5
1.6
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
12
92
1.31
0.32
1.1
1.6
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
13
101
1.29
0.31
5.1
6.6
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
27
316
0.85
0.31
1.0
1.1
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
7
96
0.73
0.31
2.4
2.7
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
27
315
0.85
0.31
1.0
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
7
53
1.32
0.31
1.3
2.2
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
7
98
0.71
0.30
1.9
2.0
—
—
—
0
0
(3017704) Immunofixation for Urine
7
54
1.30
0.30
1.4
1.6
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
21
175
1.20
0.30
1.1
1.3
nmol/l
—
0.5
—
0
10
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
112
1045
1.08
0.30
3.2
4.1
ug/l
5.1
28.0
1.73
96
818
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
7
55
1.27
0.30
3.6
2.8
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
54
487
1.11
0.29
3.4
2.5
%
0.6
0.7
0.72
54
471
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
33
377
0.87
0.29
1.6
1.4
nmol/l
0.7
0.5
0.51
26
306
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
268
2574
1.05
0.29
1.3
1.3
u/ml
6.5
11.1
0.88
97
1081
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
11
85
1.30
0.28
1.5
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
21
177
1.19
0.27
1.6
1.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
15
183
0.82
0.27
1.2
1.3
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
21
177
1.19
0.27
1.0
1.1
%
107.0
96.9
1.28
21
167
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
90
837
1.08
0.27
3.9
3.7
ng/l
81.0
79.0
0.09
80
749
(3020891) Body temperature
45
404
1.12
0.27
7.2
4.8
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
8
67
1.19
0.26
1.3
1.3
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
35
394
0.89
0.26
1.1
1.1
u/ml
1.5
1.4
0.01
14
160
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1307
13180
0.96
0.26
3.8
3.9
mmol/l
5.7
5.8
0.80
1198
12298
(40765089) Chromosome analysis panel - Blood by G-banded
5
73
0.68
0.26
1.2
1.0
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
37
330
1.12
0.25
4.1
8.4
mmol/l
1.3
1.2
0.25
31
284
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
131
1381
0.94
0.24
5.9
6.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
26
227
1.15
0.24
2.6
2.8
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
5
38
1.32
0.23
1.8
1.6
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
38
1.32
0.23
1.0
1.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
331
3214
1.04
0.23
2.1
2.3
umol/l
1127.9
4642.9
2.91
294
2825
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
39
1.28
0.23
2.0
1.3
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
5
40
1.25
0.22
1.0
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
41
372
1.10
0.22
1.5
1.4
ug/g
320.7
312.0
0.09
26
203
(3022475) Manganese [Moles/volume] in Blood
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3015665) Acarus siro IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
0.0
—
0
5
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
10
0.00
0.21
0.0
1.1
—
8.1
—
0
10
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.2
—
11.3
—
0
10
(3014891) Appearance of Pleural fluid
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
35
315
1.11
0.21
1.2
1.2
u/ml
303.9
250.7
0.43
22
193
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
13
156
0.83
0.21
1.8
1.5
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
0
12
0.00
0.21
0.0
1.0
—
8.0
—
0
6
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
2.2
—
39.5
—
0
13
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
35
316
1.11
0.20
2.8
3.2
mg/l
1.6
1.4
0.76
29
294
(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.1
—
48.9
—
0
5
(3051339) Copper [Moles/volume] in Blood
0
14
0.00
0.20
0.0
1.1
—
16.0
—
0
14
(40762814) Titanium [Mass/volume] in Blood
0
14
0.00
0.20
0.0
2.3
—
3.8
—
0
5
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
6
48
1.25
0.20
1.2
1.3
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
6
49
1.23
0.20
3.3
2.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
6
49
1.23
0.20
3.3
2.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
63
587
1.08
0.20
3.6
2.8
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
30
269
1.12
0.20
4.1
3.6
mg/l
38.3
24.4
1.05
19
176
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
6
50
1.20
0.19
3.5
2.1
—
—
—
0
0
(3004451) EKG impression Narrative
6
50
1.20
0.19
1.0
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
96
909
1.06
0.19
1.3
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
79
839
0.94
0.19
3.0
2.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
49
452
1.09
0.19
1.2
1.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
126
1203
1.05
0.19
1.5
1.3
iu/l
25.4
26.6
0.15
112
1033
(3000475) Leukocytes [#/volume] in Synovial fluid
30
270
1.11
0.19
1.8
1.8
e6/l
6141.3
11037.3
0.98
21
204
(3000492) Spirometry study
140
1459
0.96
0.18
1.4
1.4
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
31
342
0.90
0.18
1.0
1.1
u/ml
0.3
2.3
—
9
81
(3027008) Opiates [Presence] in Urine
79
836
0.94
0.18
2.9
2.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
10
121
0.83
0.18
1.2
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
49
455
1.08
0.17
1.2
1.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
7
62
1.13
0.17
3.0
2.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
7
62
1.13
0.17
3.0
2.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
7
62
1.13
0.17
3.0
2.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
7
62
1.13
0.17
3.0
2.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
32
292
1.10
0.16
1.3
1.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
654
6452
1.02
0.16
4.2
3.9
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
23
206
1.12
0.16
2.0
1.7
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
6
76
0.79
0.15
1.0
1.1
%
101.3
92.4
—
6
63
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
41
380
1.08
0.15
4.0
3.4
u/ml
51.4
1191.7
1.55
36
323
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
29
264
1.10
0.15
2.5
2.5
ug/min
20.6
112.9
2.78
21
171
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
33
303
1.09
0.15
2.0
1.6
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
11
129
0.85
0.14
2.5
1.8
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
79
829
0.95
0.14
2.9
2.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
56
594
0.94
0.14
2.0
2.3
—
—
—
0
0
(4306422)
27
246
1.10
0.14
1.1
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
49
460
1.07
0.14
1.2
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
229
2346
0.97
0.13
1.6
1.7
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
11
128
0.86
0.13
1.1
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
93
969
0.96
0.13
1.2
1.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
9
107
0.84
0.13
1.0
1.3
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
26
238
1.09
0.13
1.1
1.1
%
129.8
118.7
0.68
26
220
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
9
108
0.83
0.13
2.6
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
9
108
0.83
0.13
2.6
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
9
108
0.83
0.13
2.6
1.7
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
9
110
0.82
0.13
1.0
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
33
306
1.08
0.13
1.8
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
79
824
0.96
0.12
2.9
2.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
74
773
0.96
0.12
1.4
1.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
12
105
1.14
0.11
3.0
2.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
31
332
0.93
0.11
1.2
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
13
115
1.13
0.10
1.1
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
11
96
1.15
0.10
2.5
2.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
338
3430
0.98
0.10
1.5
1.6
mmol/l
1.4
1.4
0.33
279
2960
(40768446) Kidney Pathology biopsy report
5
45
1.11
0.09
1.6
1.5
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
5
46
1.09
0.09
1.6
3.5
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
76
733
1.04
0.09
2.4
2.9
ng/l
165.8
147.3
0.23
71
657
(3025577) Chromium [Mass/volume] in Blood
5
48
1.04
0.09
3.6
2.2
ug/l
5.0
2.1
—
5
41
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
32
301
1.06
0.09
1.4
1.3
—
18.9
—
0
5
(3026250) Tacrolimus [Mass/volume] in Blood
6
55
1.09
0.09
43.3
29.3
ug/l
7.7
7.5
—
6
50
(3045788) Cell count panel - Pleural fluid
6
56
1.07
0.08
1.5
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
67
694
0.96
0.08
1.0
1.1
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
5
64
0.78
0.08
1.8
2.5
—
14.3
—
0
7
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
13
117
1.11
0.08
1.0
1.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
13
117
1.11
0.08
1.0
1.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
11
123
0.89
0.08
1.8
2.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
68
658
1.03
0.07
3.2
2.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
6
73
0.82
0.07
1.8
1.5
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
27
286
0.94
0.07
1.1
1.2
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
8
78
1.03
0.07
1.1
1.2
mmol/l
7.3
6.5
—
8
70
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
124
1266
0.98
0.07
2.7
2.7
ug/l
0.7
0.7
0.19
72
751
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
9
85
1.06
0.07
1.0
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
25
265
0.94
0.07
1.0
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
96
983
0.98
0.06
2.1
2.3
ml/min/173m2
72.5
74.4
0.15
38
371
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
8
95
0.84
0.06
1.3
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
59
609
0.97
0.06
1.7
1.7
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
9
100
0.90
0.06
1.2
1.3
—
1.4
—
0
5
(3044927) Protein electrophoresis panel - Urine
9
102
0.88
0.06
1.1
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
28
266
1.05
0.06
1.1
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
17
158
1.08
0.06
1.1
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
19
202
0.94
0.05
1.7
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1346
13432
1.01
0.05
18.8
12.4
%
39.9
40.0
0.20
1029
10675
(3045683) HLA typing for celiac disease panel - Blood or Tissue
12
110
1.09
0.05
1.1
1.0
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
16
171
0.94
0.05
1.3
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
18
169
1.07
0.05
1.6
1.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
327
3244
1.01
0.04
4.6
4.0
mg/mmol
9.3
9.0
0.03
196
2063
(3023430) Cat dander IgE Ab [Units/volume] in Serum
26
272
0.96
0.04
1.0
1.1
u/ml
4.6
5.5
0.09
12
102
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
10
91
1.10
0.04
1.6
1.8
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
24
251
0.96
0.04
1.3
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
27
259
1.04
0.04
1.1
1.1
—
—
—
0
0
(44813793)
10
109
0.92
0.04
1.1
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
148
1463
1.01
0.03
3.8
3.8
%
32.0
31.9
0.02
115
1059
(4010399)
91
896
1.02
0.03
1.3
1.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
28
270
1.04
0.03
1.4
1.3
u/ml
96.5
106.1
—
8
52
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1217
12149
1.01
0.03
4.7
4.8
mmol/mol
38.3
38.5
0.33
1132
11468
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
30
291
1.03
0.02
1.4
1.4
—
—
—
0
0
(4035726)
105
1061
0.99
0.02
1.6
1.4
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
11
103
1.07
0.02
2.0
2.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
359
3578
1.00
0.01
3.8
3.2
mmol/l
7.5
7.8
0.46
304
3070
(3012516) Albumin [Mass/volume] in Urine
308
3091
1.00
0.01
3.9
3.3
mg/l
811.9
346.7
0.53
179
1961
(3014133) Dog dander IgE Ab [Units/volume] in Serum
31
303
1.02
0.01
1.0
1.0
u/ml
1.5
4.2
1.30
17
111
(21494434) Karyotype in Bone marrow
10
94
1.06
0.01
1.0
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
172
1714
1.00
0.00
4.4
3.8
%
23.5
21.3
0.85
71
716
(40768441) Liver Pathology biopsy report
10
105
0.95
0.00
1.0
1.4
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
12
125
0.96
0.00
1.3
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
16
165
0.97
0.00
1.4
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
16
165
0.97
0.00
1.4
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
16
165
0.97
0.00
1.4
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
16
165
0.97
0.00
1.4
1.5
—
—
—
0
0
(4281824)
14
139
1.01
0.00
1.1
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
10
104
0.96
0.00
2.9
3.7
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
17
174
0.98
0.00
1.5
1.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
77
774
0.99
0.00
2.9
2.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
16
158
1.01
0.00
1.1
1.3
nmol/l
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
11
112
0.98
0.00
1.5
1.6
mmol/l
5.8
6.5
—
6
80
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
13
132
0.98
0.00
1.9
1.2
u/ml
2.9
0.8
—
6
50
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
90
901
1.00
0.00
1.1
1.0
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
16
163
0.98
0.00
1.4
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
16
163
0.98
0.00
1.4
1.5
—
—
—
0
0
(4094501)
30
303
0.99
0.00
1.0
1.1
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
6
68
0.88
0.00
1.0
2.1
ug/l
21.4
139.4
—
6
59
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
8
0.00
0.00
0.0
7.4
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
0
8
0.00
0.00
0.0
2.4
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3013762) Body weight Measured
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
118.8
—
0
5
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
6
0.00
0.00
0.0
8.0
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
9
96
0.94
0.00
1.1
1.2
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.0
—
180.9
—
0
7
(3000936) Kiwifruit IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
1.0
—
0
5
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
6
59
1.02
0.00
1.8
2.2
mg/l
11.2
9.3
—
6
49
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
8
80
1.00
0.00
1.3
1.2
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
1.5
—
0
5
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
8
85
0.94
0.00
1.9
1.8
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
7
69
1.01
0.00
1.0
1.0
—
3.9
—
0
11
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
8
81
0.99
0.00
1.1
1.3
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758358) Immune stain study
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
5
52
0.96
0.00
1.0
2.0
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
5
55
0.91
0.00
1.8
1.7
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3036180) Methadone [Presence] in Urine
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint H7_OPTNEURITIS and mortality.

Females

Parameter HR [95% CI] p-value
H7_OPTNEURITIS 1.515 [1.3, 1.76] < 0.001
Birth year 0.997 [0.99, 1.01] 0.525

During the follow-up period (1.1.1998 — 31.12.2019), 352 out of 4881 females with H7_OPTNEURITIS died.

Males

Parameter HR [95% CI] p-value
H7_OPTNEURITIS 1.457 [1.25, 1.69] < 0.001
Birth year 0.988 [0.98, 1.0] 0.009

During the follow-up period (1.1.1998 — 31.12.2019), 331 out of 2288 males with H7_OPTNEURITIS died.

Mortality risk

Mortality risk for people of age

years, who have H7_OPTNEURITIS.

N-year risk Females Males
1 0.204% 0.266%
5 0.939% 1.733%
10 2.566% 4.544%
15 4.917% 8.48%
20 8.402% 13.804%

Relationships between endpoints

↥

Index endpoint: H7_OPTNEURITIS – Optic neuritis

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data